Comparison

GHRP-6 vs Hexarelin

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

GHRP-6

Also: Growth Hormone Releasing Peptide 6, SKF-110679

Clinical Trials

One of the first synthetic GH secretagogues developed. Strongly stimulates GH release and significantly increases appetite through ghrelin receptor activation.

Growth HormoneHuman Trials
Hexarelin

Also: Examorelin, HEX

Clinical Trials

A synthetic hexapeptide GH secretagogue with the strongest GH-releasing effect among GHRPs. Also has notable cardioprotective properties independent of GH release.

Growth HormoneHuman Trials

Key Comparison Insights

  • Both peptides belong to the Growth Hormone category, suggesting similar primary applications.

Detailed Comparison

AttributeGHRP-6Hexarelin
CategoryGrowth HormoneGrowth Hormone
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionGHRP-6 binds to ghrelin receptors (GHSR-1a) in the hypothalamus and pituitary, triggering a strong GH release. It also activates the hunger-signaling pathway, leading to significant appetite increase. Stimulates cortisol and prolactin more than newer GHRPs.Hexarelin activates ghrelin receptors (GHSR-1a) causing potent GH release. Uniquely, it also binds to CD36 receptors in cardiac tissue, providing cardioprotective effects independent of GH. Causes significant cortisol and prolactin elevation.
Common Dosing
100-300 mcg 2-3x daily
2-3x daily
100-200 mcg 2-3x daily
2-3x daily
AdministrationSubcutaneous injection, ideally fastedSubcutaneous injection
Typical Duration8-12 weeks4-8 weeks (desensitization occurs)
Best Time to TakeBefore bed or morning (fasted)Morning and before bed (fasted)
Possible Side Effects
May vary by individual
  • Significant hunger increase (most pronounced of all GHRPs)
  • Water retention
  • Elevated cortisol levels
  • Elevated prolactin levels
  • Flushing
  • +4 more
  • Increased appetite
  • Water retention
  • Tingling/numbness
  • Elevated cortisol and prolactin
  • Flushing
  • +3 more
Research SummaryWell-studied peptide showing reliable GH release. Research demonstrates cardioprotective effects in animal models, improved wound healing, and significant appetite stimulation. Studies show 3-6 fold increase in GH levels.Studies show the highest GH release among GHRPs but with desensitization over time. Cardiac research demonstrates protection against ischemia and improved heart function. Used in GH deficiency diagnosis due to reliable GH stimulation.

Frequently Asked Questions: GHRP-6 vs Hexarelin

What is the difference between GHRP-6 and Hexarelin?

GHRP-6 is a growth hormone peptide that one of the first synthetic gh secretagogues developed. strongly stimulates gh release and significantly increases appetite through ghrelin receptor activation. Hexarelin is a growth hormone peptide that a synthetic hexapeptide gh secretagogue with the strongest gh-releasing effect among ghrps. also has notable cardioprotective properties independent of gh release. The main differences lie in their mechanisms of action and clinical applications.

Which is better, GHRP-6 or Hexarelin?

Neither is universally "better" - the choice depends on your specific goals. GHRP-6 is typically used for growth hormone purposes, while Hexarelin is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can GHRP-6 and Hexarelin be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using GHRP-6 and Hexarelin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of GHRP-6 and Hexarelin is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.